enfortumab vedotin, VINFLUNINE , DOCETAXEL , PACLITAXEL
7465-CL-0301
Phase 3 small_molecule active
Quick answer
enfortumab vedotin, VINFLUNINE , DOCETAXEL , PACLITAXEL for Locally advanced or metastatic urothelial cancer is a Phase 3 program (small_molecule) at Astellas Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma GmbH
- Indication
- Locally advanced or metastatic urothelial cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active